ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

VICENTE GARCIA-ALVAREZ M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

39,970Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 3593

$787K Total Retail Price of All Prescriptions

Rank: 235 out of 3593

1,769 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,769 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 1,769 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 37,568 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$20 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 2,407 2,302 1 1
OMEPRAZOLE 1,855 1,797 2 5
METFORMIN HCL 1,234 1,138 3 6
LISINOPRIL 1,113 1,008 4 2
HYDROCHLOROTHIAZIDE 1,091 1,045 5 10
VITAMIN D2 992 925 6 124
AMLODIPINE BESYLATE 849 771 7 3
WARFARIN SODIUM 841 829 8 18
ATORVASTATIN CALCIUM 832 795 9 15
ATENOLOL 704 662 10 11
RENAL CAPS 681 638 11 112
ALENDRONATE SODIUM 675 667 12 22
IBUPROFEN 623 546 13 43
METOPROLOL TARTRATE 614 571 14 8
LOSARTAN POTASSIUM 598 577 15 14
TEMAZEPAM 581 552 16 56
ZOLPIDEM TARTRATE 566 514 17 12
LORATADINE 563 525 18 129
ENALAPRIL MALEATE 555 549 19 38
RANITIDINE HCL 548 522 20 27
LOSARTAN-HYDROCHLOROTHIAZIDE 518 508 21 48
ALPRAZOLAM 503 476 22 37
VIAGRA 497 452 23 84
METOPROLOL SUCCINATE 493 477 24 19
SYNTHROID 463 436 25 51
LEVOXYL 459 449 26 111
CITALOPRAM HBR 396 368 27 25
MELOXICAM 379 348 28 29
LANSOPRAZOLE 371 346 29 113
AMMONIUM LACTATE 366 334 30 125
GABAPENTIN 362 358 31 16
TAMSULOSIN HCL 358 354 32 33
DONEPEZIL HCL 356 349 33 31
FOLIC ACID 329 316 34 117
FLUTICASONE PROPIONATE 313 291 35 32
CLOTRIMAZOLE-BETAMETHASONE 294 271 36 94
FINASTERIDE 287 284 37 79
GLIPIZIDE 281 242 38 40
CARVEDILOL 279 265 39 23
FUROSEMIDE 271 263 40 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 261 257 41 26
CICLOPIROX 261 249 41 170
FENOFIBRATE 244 219 43 39
HYDROCODONE-ACETAMINOPHEN 234 220 S3 44 7
DICLOFENAC SODIUM 228 216 45 74
DOXAZOSIN MESYLATE 228 228 45 63
CLONAZEPAM 214 208 47 164
LORAZEPAM 211 201 48 98
KETOCONAZOLE 211 195 48 118
DILTIAZEM 24HR ER 206 190 50 177
CRESTOR 200 182 51 21
LOVASTATIN 199 199 52 20
VENTOLIN HFA 188 154 53 80
SERTRALINE HCL 183 163 54 28
PANTOPRAZOLE SODIUM 182 171 55 45
LIDODERM 172 161 56 78
PAROXETINE HCL 168 168 57 62
ROBAFEN-DM CLEAR 165 153 58 241
DIOVAN HCT 162 146 59 76
CLOPIDOGREL 160 140 60 30
GLIPIZIDE XL 159 128 61 179
ADVAIR DISKUS 157 152 62 47
BACLOFEN 154 144 63 109
CIALIS 154 136 63 176
AMLODIPINE BESYLATE-BENAZEPRIL 153 153 65 65
VOLTAREN 144 140 66 85
GLYBURIDE 142 142 R 67 55
MECLIZINE HCL 142 139 67 96
SURE COMFORT 141 107 69 159
GEMFIBROZIL 137 123 70 88
ACTOS 133 132 71 133
LANOXIN 133 133 71 223
SINGULAIR 129 119 73 77
ALLOPURINOL 128 127 74 35
NEXIUM 124 85 75 36
PLAVIX 120 106 76 42
DETROL LA 119 119 77 262
DIOVAN 115 112 78 46
LANTUS SOLOSTAR 113 98 79 122
LEVOTHYROXINE SODIUM 112 100 80 4
ATENOLOL-CHLORTHALIDONE 111 111 81 191
LANTUS 109 77 82 57
ESCITALOPRAM OXALATE 109 108 82 71
CETIRIZINE HCL 109 108 82 225
LOPERAMIDE 107 99 85 277
METOCLOPRAMIDE HCL 106 102 86 145
BENICAR 106 106 86 131
CLONIDINE HCL 105 104 88 41
ISOSORBIDE MONONITRATE ER 103 103 89 61
PRAVASTATIN SODIUM 102 101 90 13
GALANTAMINE HBR 100 100 91 239
NIFEDIPINE ER 91 64 92 75
BENZONATATE 91 86 92 377
PROCTOZONE-HC 89 83 94 209
BENICAR HCT 87 87 95 155
CLOBETASOL PROPIONATE 86 83 96 187
GLIMEPIRIDE 86 86 96 44
NAPROXEN 82 67 98 68
NAMENDA 78 78 99 50
GLYBURIDE-METFORMIN HCL 77 77 R 100 95
FAMOTIDINE 76 73 101 70
KLOR-CON 10 74 67 102 114
MI ACID 72 63 103 272
MONTELUKAST SODIUM 71 65 104 151
TRIAMTERENE-HCTZ 71 71 104 66
TENIVAC 71 54 10 104 434
VERAPAMIL ER 69 69 107 99
CILOSTAZOL 68 68 108 163
SPIRIVA 64 64 109 87
FOLBIC 64 59 109 290
HYDRALAZINE HCL 61 61 111 107
TRAMADOL HCL 61 56 111 17
CIPROFLOXACIN HCL 60 60 113 52
CYMBALTA 59 57 114 73
FLUNISOLIDE 59 59 114 261
DESONIDE 59 57 114 315
AZITHROMYCIN 58 54 117 34
FLUOXETINE HCL 58 58 117 60
KLOR-CON M20 58 58 117 139
RISPERIDONE 58 55 117 83
DICYCLOMINE HCL 58 55 117 190
METFORMIN HCL ER 58 57 117 67
TRIAMCINOLONE ACETONIDE 56 51 123 119
CARBIDOPA-LEVODOPA 54 54 124 135
ESTAZOLAM 54 54 124 327
VALSARTAN-HYDROCHLOROTHIAZIDE 53 50 126 412
BETAMETHASONE DIPROPIONATE 51 48 127 305
JANUMET 51 21 127 238
PRIMIDONE 51 51 127 282
MUPIROCIN 50 48 130 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.